Hemangiopericytoma
Symptoms, Doctors, Treatments, Advances & More

Hemangiopericytoma Overview

Save information for later
Sign Up

Learn About Hemangiopericytoma

View Main Condition: Brain Tumor

What is the definition of Hemangiopericytoma?
Hemangiopericytoma is a term used to described a group of tumors that are derived from pericytes, the cells normally arranged along specific types of blood vessels called capillaries and venules. These types of tumors are typically slow-growing, may be either benign (non-cancerous) or malignant (cancerous), and may occur anywhere in the body.
What are the alternative names for Hemangiopericytoma?
  • Hemangiopericytoma
Who are the top Hemangiopericytoma Local Doctors?
Elite in Hemangiopericytoma
Elite in Hemangiopericytoma
Referral may be required
No.1 XinSi Road, 
Xi'an, CN 

Yingxi Wu practices practicing medicine in Xi'an, China. Wu is rated as an Elite expert by MediFind in the treatment of Hemangiopericytoma. They are also highly rated in 4 other conditions, according to our data. Their clinical expertise encompasses Hemangiopericytoma, Brain Herniation, Schwannoma, Acoustic Neuroma, and Oophorectomy.

Experienced in Hemangiopericytoma
Dr. Sidney M. Jacoby
Orthopedics | Hand Surgery
Experienced in Hemangiopericytoma
Dr. Sidney M. Jacoby
Orthopedics | Hand Surgery
Referral may be required

The Philadelphia Hand To Shoulder Center

950 Pulaski Dr, Ste 100, 
King Of Prussia, PA 
800-385-7472
Languages Spoken:
English
See accepted insurances

Sidney Jacoby is a Hand Surgeon and an Orthopedics provider practicing medicine in King Of Prussia, Pennsylvania. Dr. Jacoby is rated as an Experienced provider by MediFind in the treatment of Hemangiopericytoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Dupuytren Contracture, Carpal Tunnel Syndrome, Rhizarthrosis, Osteotomy, and Fasciotomy. Dr. Jacoby is board certified in American Board Of Orthopaedic Surgery.

 
 
 
 
Learn about our expert tiers
Learn More
Experienced in Hemangiopericytoma
Experienced in Hemangiopericytoma
Referral may be required

ETSU Physicians & Associates- Surgery

325 N State Of Franklin Rd, 
Johnson City, TN 
423-439-7201
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Carlos Floresguerra is a General Surgeon practicing medicine in Johnson City, Tennessee. Dr. Floresguerra is rated as an Experienced provider by MediFind in the treatment of Hemangiopericytoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Hernia, Gallbladder Disease, Bladder Reconstruction, and Hernia Surgery. Dr. Floresguerra is board certified in American Board Of Surgery.

View All Doctors
What are the latest Hemangiopericytoma Clinical Trials?
Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Diagnosed According to cIMPACT-NOW Recommendations and the 2021 WHO Classification
Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Diagnosed According to cIMPACT-NOW Recommendations and the 2021 WHO Classification
Enrollment Status: Recruiting
Publish Date: December 17, 2025
Intervention Type: Other

Summary: Every new classification depends on its prognostic power and on the type of treatment given. With the rapid evolution of diagnostic methods and the advance in new treatments, there is much less reliable information available on how patients with newly defined brain tumour entities should be treated and what to expect from the current treatments. The goal is to determine whether the new 2021 WHO cl...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology
Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology
Enrollment Status: Recruiting
Publish Date: November 26, 2024
Intervention Type: Other

Summary: The first proton therapy treatments in the Netherlands have taken place in 2018. Due to the physical properties of protons, proton therapy has tremendous potential to reduce the radiation dose to the healthy, tumour-surrounding tissues. In turn, this leads to less radiation-induced complications, and a decrease in the formation of secondary tumours. The Netherlands has spearheaded the development ...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center